Nxera Pharma Co., Ltd. (4565.T)
JPY 1056.0
(1.15%)
JPY 1056.0
(1.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.27 Billion | 9.95 Billion | 7.09 Billion | 4.67 Billion | 3.44 Billion | -3.99 Billion |
| Net Income | -7.19 Billion | 1.07 Billion | 433 Million | 1.62 Billion | 534 Million | -7.94 Billion |
| Depreciation & Amortization | 2.47 Billion | 1.34 Billion | 1.27 Billion | 1.35 Billion | 1.48 Billion | 1.37 Billion |
| Deferred income taxes | -1.05 Billion | - | 2.64 Billion | 1.45 Billion | 1.43 Billion | - |
| Stock-based compensation | 870 Million | 700 Million | 713 Million | 626 Million | 384 Million | - |
| Change in working capital | 1.6 Billion | 5.25 Billion | -1.78 Billion | 1.36 Billion | 258 Million | 198 Million |
| Other non-cash items | -1.98 Billion | 1.57 Billion | 3.8 Billion | -1.74 Billion | -663 Million | 4.93 Billion |
| Investing Cash Flow | -63.79 Billion | 1.04 Billion | 278 Million | -150 Million | -246 Million | -2.8 Billion |
| Investments in PPE | -851 Million | -303 Million | -201 Million | -105 Million | -280 Million | -2.15 Billion |
| Acquisitions | -62.94 Billion | 137 Million | 206 Million | -577 Million | -9 Million | - |
| Investment purchases | - | -137 Million | -206 Million | 577 Million | -250 Million | -650 Million |
| Sales/Maturities of investments | - | 1.2 Billion | 206 Million | 533 Million | 264 Million | - |
| Other Investing Activities | 1 Million | 137 Million | 273 Million | -578 Million | 29 Million | 1 Million |
| Financing Cash Flow | 48.32 Billion | -4.88 Billion | 11.12 Billion | 20.27 Billion | -6.96 Billion | -2.26 Billion |
| Debt repayment | -70.15 Billion | - | -18.95 Billion | -15.9 Billion | -7.06 Billion | -2.25 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -140 Million |
| Common Stock Issuance | 9.98 Billion | - | 600 Million | 5.14 Billion | 747 Million | 84 Million |
| Other Financing Activities | -31.32 Billion | -4.88 Billion | 29.48 Billion | 15.13 Billion | -650 Million | -97 Million |
| Accounts receivables | 1.31 Billion | -210 Million | -799 Million | 752 Million | -923 Million | -19 Million |
| Accounts payables | 1.55 Billion | 315 Million | -184 Million | 61 Million | -258 Million | 210 Million |
| Inventory | 1.9 Billion | -32 Million | -495 Million | -161 Million | 54 Million | - |
| Other working capital | -3.16 Billion | 5.18 Billion | -305 Million | 712 Million | 1.38 Billion | 7 Million |
| Cash at beginning of period | 66.55 Billion | 60.08 Billion | 40 Billion | 15.37 Billion | 18.76 Billion | 13.89 Billion |
| Cash at end of period | 49.06 Billion | 66.55 Billion | 60.08 Billion | 40 Billion | 15.37 Billion | 18.76 Billion |
| Capital Expenditure | -851 Million | -303 Million | -201 Million | -105 Million | -280 Million | -2.15 Billion |
| Effect of forex changes on cash | 3.24 Billion | 362 Million | 1.58 Billion | -167 Million | 384 Million | -804 Million |
| Net cash flow / Change in cash | -17.49 Billion | 6.47 Billion | 20.07 Billion | 24.63 Billion | -3.38 Billion | 4.86 Billion |
| Free Cash Flow | -6.12 Billion | 9.64 Billion | 6.89 Billion | 4.56 Billion | 3.16 Billion | -6.15 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.2 Billion | -1.42 Billion | -3.28 Billion | -208 Million | -7.19 Billion | -4.1 Billion |
| Depreciation & Amortization | 994 Million | 1 Billion | 983 Million | 982 Million | 2.47 Billion | 795 Million |
| Deferred income taxes | - | - | - | -2.39 Billion | -1.05 Billion | 243 Million |
| Stock-based compensation | - | 399 Million | 234 Million | 276 Million | 870 Million | 240 Million |
| Change in working capital | -422 Million | 2.73 Billion | -521 Million | -776 Million | 1.6 Billion | 1.24 Billion |
| Other non-cash items | -31 Million | 5.23 Billion | 1.07 Billion | 1.28 Billion | -1.98 Billion | 119 Million |
| Investing Cash Flow | -253 Million | 484 Million | -50 Million | -850 Million | -63.79 Billion | -61.18 Billion |
| Investments in PPE | -271 Million | -56 Million | -49 Million | -338 Million | -851 Million | -301 Million |
| Acquisitions | - | - | - | -513 Million | -62.94 Billion | -62.42 Billion |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 24 Million | 1 Million | -1 Million | 1 Million | 1 Million | 1.54 Billion |
| Financing Cash Flow | -1.68 Billion | -1.67 Billion | -1.82 Billion | 8.73 Billion | 48.32 Billion | 39.7 Billion |
| Debt repayment | -1.45 Billion | -1.45 Billion | -1.6 Billion | -30.25 Billion | -70.15 Billion | -39.9 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 9.98 Billion | 9.98 Billion | - |
| Other Financing Activities | -232 Million | 12 Million | -13 Million | -31.31 Billion | -31.32 Billion | -12 Million |
| Accounts receivables | 1.43 Billion | -2.35 Billion | 1.94 Billion | -1.13 Billion | 1.31 Billion | 721 Million |
| Accounts payables | -887 Million | 758 Million | -1.25 Billion | 984 Million | 1.55 Billion | 762 Million |
| Inventory | 683 Million | -228 Million | 817 Million | 1.9 Billion | 1.9 Billion | - |
| Other working capital | -1.65 Billion | 4.56 Billion | -2.02 Billion | -2.53 Billion | -3.16 Billion | -241 Million |
| Cash at beginning of period | 50.98 Billion | 46.51 Billion | 49.06 Billion | 42.38 Billion | 66.55 Billion | 65.59 Billion |
| Cash at end of period | 48.86 Billion | 50.98 Billion | 46.51 Billion | 49.06 Billion | 49.06 Billion | 42.38 Billion |
| Capital Expenditure | -271 Million | -56 Million | -49 Million | -338 Million | -851 Million | -301 Million |
| Effect of forex changes on cash | - | 1.94 Billion | 1.52 Billion | -377 Million | 3.24 Billion | -260 Million |
| Net cash flow / Change in cash | -2.11 Billion | 4.46 Billion | -2.55 Billion | 6.67 Billion | -17.49 Billion | -23.21 Billion |
| Free Cash Flow | 1.47 Billion | 3.66 Billion | -2.25 Billion | -1.16 Billion | -6.12 Billion | -1.76 Billion |
3738
VIJAYA
8107
6504
CVGI
0I7E